Validation of Accexible as a Tool for Screening and Monitoring Depression.
NCT: NCT06044818 · COMPLETED
Brief Summary
Major depressive disorder (MDD) is a chronic disease with a prevalence around 8-12% and is considered one of the most debilitating disease worldwide. A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness. The present study has the objective of validating Accexible as a tool for Screening and Monitoring Depression.
Frequently Asked Questions
What is Validation of Accexible as a Tool for Screening and Monitoring Depression.?
Validation of Accexible as a Tool for Screening and Monitoring Depression. is a clinical trial registered under NCT06044818. Current status: COMPLETED.
What is the status of NCT06044818?
The current status of NCT06044818 (Validation of Accexible as a Tool for Screening and Monitoring Depression.) is: COMPLETED.
When did Validation of Accexible as a Tool for Screening and Monitoring Depression. start?
Validation of Accexible as a Tool for Screening and Monitoring Depression. started on 2023-07-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.